Minimal residual disease-directed therapy in acute myeloid leukemia
Case 1: A 35-year-old man with a normal white blood cell (WBC) count (9.3 × 10 9 /L) was diagnosed with acute myeloid leukemia (AML) with a t(8;21)(q22;q22) translocation in 25/25 metaphases. The RUNX1-RUNX1T1 fusion gene was detected by real-time quantitative polymerase chain reaction (PCR),
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
28 January 2015
|
| In: |
Blood
Year: 2015, Jahrgang: 125, Heft: 15, Pages: 2331-2335 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2014-11-578815 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1182/blood-2014-11-578815 Verlag, kostenfrei, Volltext: http://www.bloodjournal.org/content/125/15/2331 
|
| Verfasserangaben: | Sabine Kayser, Richard F. Schlenk, David Grimwade, Victor E. D. Yosuico, and Roland B. Walter |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1560731508 | ||
| 003 | DE-627 | ||
| 005 | 20230428162058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170711s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood-2014-11-578815 |2 doi | |
| 035 | |a (DE-627)1560731508 | ||
| 035 | |a (DE-576)490731503 | ||
| 035 | |a (DE-599)BSZ490731503 | ||
| 035 | |a (OCoLC)1340977081 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kayser, Sabine |d 1979- |e VerfasserIn |0 (DE-588)138694923 |0 (DE-627)605256233 |0 (DE-576)30778813X |4 aut | |
| 245 | 1 | 0 | |a Minimal residual disease-directed therapy in acute myeloid leukemia |c Sabine Kayser, Richard F. Schlenk, David Grimwade, Victor E. D. Yosuico, and Roland B. Walter |
| 264 | 1 | |c 28 January 2015 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.07.2017 | ||
| 520 | |a Case 1: A 35-year-old man with a normal white blood cell (WBC) count (9.3 × 10 9 /L) was diagnosed with acute myeloid leukemia (AML) with a t(8;21)(q22;q22) translocation in 25/25 metaphases. The RUNX1-RUNX1T1 fusion gene was detected by real-time quantitative polymerase chain reaction (PCR), | ||
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 125(2015), 15, Seite 2331-2335 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Minimal residual disease-directed therapy in acute myeloid leukemia |
| 773 | 1 | 8 | |g volume:125 |g year:2015 |g number:15 |g pages:2331-2335 |g extent:5 |a Minimal residual disease-directed therapy in acute myeloid leukemia |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1182/blood-2014-11-578815 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://www.bloodjournal.org/content/125/15/2331 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170711 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 138694923 |a Kayser, Sabine |m 138694923:Kayser, Sabine |d 910000 |d 910100 |e 910000PK138694923 |e 910100PK138694923 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1560731508 |e 2973685680 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 11.07.2017"],"person":[{"display":"Kayser, Sabine","given":"Sabine","role":"aut","family":"Kayser"}],"recId":"1560731508","language":["eng"],"name":{"displayForm":["Sabine Kayser, Richard F. Schlenk, David Grimwade, Victor E. D. Yosuico, and Roland B. Walter"]},"origin":[{"dateIssuedDisp":"28 January 2015","dateIssuedKey":"2015"}],"relHost":[{"note":["Gesehen am 21.04.2023"],"pubHistory":["1.1946 -"],"part":{"issue":"15","extent":"5","pages":"2331-2335","text":"125(2015), 15, Seite 2331-2335","year":"2015","volume":"125"},"language":["eng"],"titleAlt":[{"title":"Blood online"}],"disp":"Minimal residual disease-directed therapy in acute myeloid leukemiaBlood","type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"role":"isb","display":"American Society of Hematology"}],"recId":"266886647","origin":[{"dateIssuedKey":"1946","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedDisp":"1946-"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["1468538-3"],"issn":["1528-0020"],"eki":["266886647"]},"title":[{"title_sort":"Blood","title":"Blood","subtitle":"journal of the American Society of Hematology"}]}],"id":{"eki":["1560731508"],"doi":["10.1182/blood-2014-11-578815"]},"physDesc":[{"extent":"5 S."}],"title":[{"title":"Minimal residual disease-directed therapy in acute myeloid leukemia","title_sort":"Minimal residual disease-directed therapy in acute myeloid leukemia"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a KAYSERSABIMINIMALRES2820 | ||